The Federal Reserve Building in downtown Washington DC, USA at night. HDR image. Quantitative Tightening (QT) has been a hot topic for investors, especially those in the U.S. equities market. While ...

News provided by EIN Presswire Mar 14, 2023, 10:00 AM ET MONTREAL, QUEBEC, CANADA, March 14, 2023 / EINPresswire.com / -- Thryv Therapeutics Inc. Announces Completion of Initial Phase 1 Clinical Study ...

The completion of this phase 1 clinical study is a major development milestone for Thryv Therapeutics as its portfolio of SGK inhibitors continues to expand and advance. Upregulation of SGK has been ...

Thryv Therapeutics Inc., a clinical stage biotechnology company developing therapies for rare diseases including Congenital Long QT Syndrome (LQTS) and resistant cancers as well as atrial fibrillation ...